A study on chronic hair loss in women - possible mechanisms
Not Applicable
- Conditions
- Health Condition 1: L650- Telogen effluvium
- Registration Number
- CTRI/2021/05/033731
- Lead Sponsor
- IADV
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
CTE: Persistent hair shedding beyond 6 months with no trigger discernible on clinical evaluation or investigations including CBC/LFT/KFT/ VIT D3/TFT/ANA/Blood sugar/ serum ferritin/ serum folate/ Vit B12 (as per attached case record form) with absence of features suggestive of androgenetic alopecia on trichoscopy
Exclusion Criteria
Both cases and controls:
• Systemic co-morbidites (Chronic illness/ hypothyroidism/ surgery / HTN/DM/Asthma /TB/PCOD/any other)
•systemic/topical drugs
•pregnancy and lactation
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To see the relevance of jak stat pathway in CTETimepoint: At completion of IHC procedure. 1 year
- Secondary Outcome Measures
Name Time Method to seek pharmacological relevance of jak stat pathway in CTETimepoint: 1 year